CLINICAL_TRIALS
trial_result
· 2017-07-02
Clinical Trial Update: Safety and Immunogenicity Study of a Live Francisella Tularensis Vaccine [Phase 2]
Summary
Phase 2 safety and immunogenicity study of a live Francisella tularensis vaccine completed.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: U.S. Army Medical Research and Development Command | Conditions: Tularemia | Phase 2 | Status: COMPLETED | Results posted: 2017-07-02